Summary: In the newest issue of The New England Journal of Medicine, famed health care economist Victor Fuchs argues that: “Current demographic, social, and economic forces will create new priorities for future biomedical innovations: more emphasis on improving quality of life and less on extending life, and more attention to value-enhancing innovations instead of pursuit of any medical advance regardless of its cost relative to its benefit.”
Sunday, Matthew Holt published a superb interview with Fuchs, (now the Henry J. Kaiser Professor Emeritus at Stanford University) on The Health Care Blog (THCB). Below, excerpts from that interview. At the end, I offer extended commentary on this exceptional interview. As always, Fuchs offers some eye-opening insights. You’ll find the complete September 19 THCB interview here.